2m 2m 2m 2m 2m 2m 2m
Cytokinetics (CYTK)
NASDAQ
$79.91-$0.11 (-0.13%)
Price as of Jun 23, 2026 7:30 PM EDT- $10.7BMarket Cap
- 142.56%1-Year Change
- BiotechnologyIndustry
Cytokinetics (CYTK)
$79.91-$0.11 (-0.13%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 14.08% | 17.5M | -192,532 (-1.10%) | Mar 31, 2026 |
BLACKROCK, INC. | 13.30% | 16.5M | +152,888 (+0.92%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 12.43% | 15.5M | +216,539 (+1.40%) | Dec 31, 2024 |
BLACKROCK INC. | 11.79% | 14.7M | +2.3M (+15.39%) | Jun 30, 2024 |
VANGUARD GROUP INC | 9.68% | 12.0M | +191,336 (+1.59%) | Dec 31, 2025 |
FMR LLC | 8.62% | 10.7M | -2.1M (-19.44%) | Mar 31, 2026 |
WELLINGTON MANAGEMENT GROUP LLP | 6.44% | 8.0M | +72,426 (+0.90%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
AQR Funds | 8.71% | 10.8M | 0 (0.00%) | Mar 31, 2026 |
iSHARES TRUST | 7.94% | 9.9M | +169,374 (+1.71%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 7.79% | 9.7M | +175,131 (+1.81%) | Mar 31, 2026 |
Virtus Investment Trust | 6.98% | 8.7M | 0 (0.00%) | Mar 31, 2026 |
Virtus Strategy Trust | 5.53% | 6.9M | +6.9M (+100.00%) | Sep 30, 2025 |
T. Rowe Price Capital Appreciation Fund, Inc. | 4.11% | 5.1M | +1.7M (+33.58%) | Mar 31, 2026 |
LORD ABBETT INVESTMENT TRUST | 3.32% | 4.1M | 0 (0.00%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions2.2B (66.34%)
- Mutual Funds1.1B (33.12%)
- Insiders17.9M (0.54%)
- Other0 (0.00%)
Insider Transactions
- 0.54% (17.9M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 7Number of InsiderSelling (last 12 months)
- $272.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Blum Robert I President & CEO | Sell | Jun 15, 2026 | $528,450.00 | 7,500 | $70.46 | 385,330 |
Malik Fady Ibraham EVP Research & Development | Exempt | Apr 07, 2026 | $0.00 | 3,500 | $0.00 | 58,386 |
Malik Fady Ibraham EVP Research & Development | Exempt | Apr 07, 2026 | $0.00 | 1,000 | $0.00 | 0 |
Malik Fady Ibraham EVP Research & Development | Exempt | Apr 07, 2026 | $27,300.00 | 3,500 | $7.80 | 157,402 |
Malik Fady Ibraham EVP Research & Development | Sell | Apr 07, 2026 | $228,235.00 | 3,500 | $65.21 | 153,902 |
Malik Fady Ibraham EVP Research & Development | Exempt | Apr 07, 2026 | $10,600.00 | 1,000 | $10.60 | 154,902 |
Malik Fady Ibraham EVP Research & Development | Sell | Apr 07, 2026 | $64,750.00 | 1,000 | $64.75 | 153,902 |
Blum Robert I President & CEO | Sell | Apr 01, 2026 | $499,725.00 | 7,500 | $66.63 | 422,830 |
Callos Andrew EVP, Chief Commercial Officer | Sell | Mar 31, 2026 | $236,535.00 | 3,639 | $65.00 | 66,004 |
Callos Andrew EVP, Chief Commercial Officer | Sell | Mar 18, 2026 | $119,795.10 | 1,930 | $62.07 | 78,185 |
Lee Sung EVP, Chief Financial Officer | Sell | Mar 17, 2026 | $306,710.25 | 4,935 | $62.15 | 87,127 |
Callos Andrew EVP, Chief Commercial Officer | Sell | Mar 16, 2026 | $104,300.27 | 1,709 | $61.03 | 46,149 |
Malik Fady Ibraham EVP Research & Development | Award | Mar 15, 2026 | $0.00 | 1,665 | $0.00 | 1,665 |
Callos Andrew EVP, Chief Commercial Officer | Award | Mar 15, 2026 | $0.00 | 1,665 | $0.00 | 1,665 |
Lee Sung EVP, Chief Financial Officer | Award | Mar 15, 2026 | $0.00 | 1,665 | $0.00 | 1,665 |
Callos Andrew EVP, Chief Commercial Officer | Award | Mar 15, 2026 | $0.00 | 29,480 | $0.00 | 29,480 |
Malik Fady Ibraham EVP Research & Development | Award | Mar 15, 2026 | $0.00 | 39,527 | $0.00 | 39,527 |
Callos Andrew EVP, Chief Commercial Officer | Award | Mar 15, 2026 | $0.00 | 20,646 | $0.00 | 68,504 |
Blum Robert I President & CEO | Award | Mar 15, 2026 | $0.00 | 1,665 | $0.00 | 1,665 |
Callos Andrew EVP, Chief Commercial Officer | Award | Mar 15, 2026 | $0.00 | 13,320 | $0.00 | 81,824 |
Malik Fady Ibraham EVP Research & Development | Award | Mar 15, 2026 | $0.00 | 27,306 | $0.00 | 165,935 |
Lee Sung EVP, Chief Financial Officer | Award | Mar 15, 2026 | $0.00 | 29,480 | $0.00 | 29,480 |
Blum Robert I President & CEO | Award | Mar 15, 2026 | $0.00 | 111,864 | $0.00 | 111,864 |
Lee Sung EVP, Chief Financial Officer | Award | Mar 15, 2026 | $0.00 | 20,646 | $0.00 | 92,062 |
Blum Robert I President & CEO | Award | Mar 15, 2026 | $0.00 | 75,258 | $0.00 | 466,931 |
Callos Andrew EVP, Chief Commercial Officer | Sell | Mar 09, 2026 | $156,779.04 | 2,582 | $60.72 | 47,858 |
Malik Fady Ibraham EVP Research & Development | Sell | Mar 09, 2026 | $176,513.04 | 2,907 | $60.72 | 138,629 |
Callos Andrew EVP, Chief Commercial Officer | Exempt | Mar 05, 2026 | $0.00 | 11,000 | $0.00 | 24,403 |
Callos Andrew EVP, Chief Commercial Officer | Exempt | Mar 05, 2026 | $0.00 | 15,000 | $0.00 | 69,000 |
Callos Andrew EVP, Chief Commercial Officer | Exempt | Mar 05, 2026 | $430,430.00 | 11,000 | $39.13 | 76,440 |